Zhongzhen Su
- Hepatology top 5%
- Biomedical Engineering
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 10%
- Epidemiology
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (19 papers)Liver Disease Diagnosis and Treatment (15 papers)MRI in cancer diagnosis (14 papers)
- Journals
- SHILAP Revista de lepidopterologíaBiomaterialsRadiology
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Zhongzhen Su
67 papers receiving 900 citations
Peers
Comparison fields: 5 of 88
- Hepatology 249
- Biomedical Engineering 227
- Molecular Biology 211
- Radiology, Nuclear Medicine and Imaging 211
- Epidemiology 193
Countries citing papers authored by Zhongzhen Su
This map shows the geographic impact of Zhongzhen Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongzhen Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongzhen Su more than expected).
Fields of papers citing papers by Zhongzhen Su
This network shows the impact of papers produced by Zhongzhen Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongzhen Su. The network helps show where Zhongzhen Su may publish in the future.
Co-authorship network of co-authors of Zhongzhen Su
This figure shows the co-authorship network connecting the top 25 collaborators of Zhongzhen Su. A scholar is included among the top collaborators of Zhongzhen Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongzhen Su. Zhongzhen Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 9 | |
| 7 | 14 | |
| 8 | 10 | |
| 9 | 7 | |
| 10 | 2 | |
| 11 | 17 | |
| 12 | 1 | |
| 13 | 4 | |
| 14 | 4 | |
| 15 | 1 | |
| 16 | 1 | |
| 17 | 0 | |
| 18 | 29 | |
| 19 | 1 | |
| 20 | 0 |
About Zhongzhen Su
Zhongzhen Su is a scholar working on Hepatology, Radiology, Nuclear Medicine and Imaging and Nephrology, having authored 77 papers that have together received 912 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Liver Disease Diagnosis and Treatment (15 papers) and MRI in cancer diagnosis (14 papers). The work is most often cited by research in Hepatology (249 citations), Otorhinolaryngology (52 citations) and Radiology, Nuclear Medicine and Imaging (211 citations). Zhongzhen Su has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Erjiao Xu, Kai Li, Rongqin Zheng, Yongquan Huang, Qingjing Zeng, Jiaxin Chen, Ziman Chen, Rongqin Zheng, Jie Ren and Liujun Li. Their work appears in journals such as SHILAP Revista de lepidopterología, Biomaterials and Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.